Randomised, double-blind, placebo-controlled, two-way crossover phase IIa proof-of-concept trial of orally administered tianeptine [REV 001] in alfentanil-induced respiratory depression
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2014
At a glance
- Drugs Tianeptine (Primary)
- Indications Respiratory insufficiency
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors Revive Therapeutics
- 27 Jun 2014 Results published in the Revive Therapeutic Media Release.
- 18 Feb 2014 New trial record
- 12 Feb 2014 Interim results published in a Revive Therapeutics media release.